Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mohammad S. Jalali, Ph.D.

Concepts (167)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Mohammad Jalali's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Mohammad Jalali has written about over time.
Computer Security, 5 publications between 2018 and 2021, average publication date July 2019. Electronic Mail, 1 publications between 2020 and 2020, average publication date January 2020. Telemedicine, 3 publications between 2020 and 2021, average publication date September 2020. Videoconferencing, 1 publications between 2021 and 2021, average publication date February 2021. Weather, 2 publications between 2020 and 2021, average publication date April 2021. Organizations, 2 publications between 2018 and 2023, average publication date May 2021. Analgesics, Opioid, 16 publications between 2020 and 2024, average publication date May 2022. Policy Making, 1 publications between 2022 and 2022, average publication date May 2022. Opioid-Related Disorders, 17 publications between 2020 and 2024, average publication date July 2022. Naloxone, 3 publications between 2020 and 2024, average publication date August 2022. Health Policy, 3 publications between 2022 and 2023, average publication date September 2022. Narcotic Antagonists, 4 publications between 2020 and 2024, average publication date September 2022. Buprenorphine, 6 publications between 2022 and 2023, average publication date December 2022.

To see the data from this visualization as text, click here.
Jalali's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (167)
Explore
_
Co-Authors (25)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.